|

Profiles of Expression in HPV+ Versus HPV Head and Neck Cancers

RECRUITINGSponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche
Actively Recruiting
SponsorGCS Ramsay Santé pour l'Enseignement et la Recherche
Started2024-01-01
Est. completion2024-06-30
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

Squamous cell cancers of the head and neck are classically correlated to excessive consumption of alcohol and tobacco and have a rather poor prognosis. However, the incidence of Head and Neck cancers in patients without alcohol-smoking risk factor has continued to increase in recent years, in relation to more and more frequent HPV contamination. Some studies show a difference in the expression of certain genes within the two groups of tumors (HPV+ and HPV-) including some that confer sensitivity to certain chemotherapies and others to radiotherapy. However, patients with HPV+ Head and Neck cancers are treated according to the same referential as HPV- Head and Neck cancers. There is therefore a real need for studies identifying predictive markers in order to be able to offer patients a more effective suitable and less invasive treatment.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patient with oropharyngeal squamous cell carcinoma or the oral cavity histologically proven.
* Primary tumor for which a biopsy or excision is required available and sufficient to carry out molecular analysis

Exclusion Criteria:

\- Patient with Head and Neck cancer other than oropharyngeal or oral cavity squamous cells carcinomas

Conditions2

CancerHead and Neck Cancer

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.